Guest
Guest
Nov 08, 2025
12:54 AM
|
Vilitra, containing Vardenafil, is a medication used to treat erectile dysfunction (ED) in men. Clinical trials are essential for evaluating its safety, efficacy, and optimal dosage. Eligibility criteria for participation in Vilitra clinical trials are carefully defined to ensure reliable results and patient safety.
Typically, male participants aged 18 and above who have been diagnosed with mild to moderate erectile dysfunction may be eligible. Candidates must have a stable sexual relationship and a history of ED lasting for at least six months. VILITRA Participants should be generally healthy, with no severe cardiovascular conditions, uncontrolled diabetes, or significant liver or kidney disease, as these factors may increase the risk of adverse effects.
Certain medications, such as nitrates, may exclude participation because of potential dangerous interactions with Vardenafil. Individuals with a history of stroke, heart attack, or severe hypotension may also be ineligible. Additional criteria may include regular health check-ups, willingness to comply with study protocols, and the ability to provide informed consent.
Clinical trial eligibility can vary depending on the phase and objectives of the study. Before enrollment, participants typically undergo a medical evaluation, lab tests, and counseling to ensure they meet all requirements.
|
